International organizations advocate for earlier detection and screening to reduce mortality from lung cancer — the world’s leading cause of cancer deaths.
RT’s Three Key Takeaways:
- Early Detection Impact: Annual low-dose computed tomography (LDCT) screening for high-risk individuals can identify lung cancer at earlier, more treatable stages and significantly reduce mortality rates.
- Screening Access Barriers: Many eligible patients face inconsistent access to screening due to geographic challenges, financial obstacles, limited availability, and a lack of awareness within healthcare systems.
- Global Advocacy Efforts: The Forum of International Respiratory Societies (FIRS) is urging governments and policymakers to expand equitable screening access to improve survival outcomes for the estimated 2.5 million people diagnosed annually.
To mark World Lung Cancer Day on Aug 1, the Forum of International Respiratory Societies (FIRS) is raising awareness about the importance of earlier detection and the need for equitable screening access.
Lung cancer remains the leading cause of cancer-related deaths worldwide, claiming an estimated 1.8 million lives in 2022, according to the World Health Organization (WHO). During that same year, approximately 2.5 million people were diagnosed with the disease.
Despite improvements in medical technology, many individuals are still diagnosed at a late stage when treatment options are more restricted. Earlier detection can improve patient outcomes, making awareness of symptoms and access to timely diagnosis critical, according to a news release from FIRS.
Annual LDCT screening for eligible, high-risk individuals has been shown to detect lung cancer at more treatable stages and reduce mortality. However, access to these screenings remains inconsistent across different countries and healthcare systems.
Many eligible individuals face significant barriers to care, including limited availability, geographic challenges, financial obstacles, and a lack of awareness. Expanding these programs for high-risk populations has the potential to improve survival rates through earlier diagnosis, the release said.
FIRS is calling on governments, healthcare systems, policymakers, and clinicians to expand equitable access to screening worldwide. The organization, which includes the American Thoracic Society (ATS) as a founding member, represents more than 70,000 members globally working to improve lung health.
